APO Research
Talk to an analyst

APO RESEARCH · REPORT

Propranolol Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Propranolol Drug Industry Growth and Trends Forecast to 2032

2 January 2026116 pages

Choose your research edition.

Industry ResearchPropranolol Drug Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Propranolol Drug Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Propranolol Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Propranolol Drug Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Propranolol Drug Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Propranolol Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Propranolol Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Propranolol Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Propranolol Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Propranolol Drug include ABZ-Pharma, Apotex, Atnahs Pharma, IFET, Intas Pharma, Iqfarma, Nichi-Iko Pharmaceutical, Sawai Seiyaku and Towa Yakuhin, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Propranolol Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Propranolol Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Propranolol Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Propranolol Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Propranolol Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Propranolol Drug Market by Company

ABZ-Pharma

Apotex

Atnahs Pharma

IFET

Intas Pharma

Iqfarma

Nichi-Iko Pharmaceutical

Sawai Seiyaku

Towa Yakuhin

Viatris

Yabang Pharma

Zentiva

Zydus Pharma

AstraZeneca

Novartis

Sanofi

Teva

Propranolol Drug Segment by Type

Oral

Injection

Propranolol Drug Segment by Application

Arrhythmia

Hypertension

Other

Propranolol Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Propranolol Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Propranolol Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Propranolol Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Propranolol Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Propranolol Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Oral Table 2. Major Company of Injection Table 3. Global Propranolol Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Propranolol Drug Sales by Type (2021-2026) & (K Units) Table 5. Global Propranolol Drug Sales Market Share in Volume by Type (2021-2026) Table 6. Global Propranolol Drug Sales by Type (2021-2026) & (US$ Million) Table 7. Global Propranolol Drug Sales Market Share in Value by Type (2021-2026) Table 8. Global Propranolol Drug Price by Type (2021-2026) & (US$/Unit) Table 9. Global Propranolol Drug Sales by Type (2027-2032) & (K Units) Table 10. Global Propranolol Drug Sales Market Share in Volume by Type (2027-2032) Table 11. Global Propranolol Drug Sales by Type (2027-2032) & (US$ Million) Table 12. Global Propranolol Drug Sales Market Share in Value by Type (2027-2032) Table 13. Global Propranolol Drug Price by Type (2027-2032) & (US$/Unit) Table 14. North America Propranolol Drug Sales by Type (2021-2026) & (K Units) Table 15. North America Propranolol Drug Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Propranolol Drug Sales by Type (2021-2026) & (K Units) Table 17. Europe Propranolol Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Propranolol Drug Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Propranolol Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Propranolol Drug Sales by Type (2021-2026) & (K Units) Table 21. Latin America Propranolol Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Propranolol Drug Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Propranolol Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Propranolol Drug Industry Trends Table 25. Propranolol Drug Industry Drivers Table 26. Propranolol Drug Industry Opportunities and Challenges Table 27. Propranolol Drug Industry Restraints Table 28. Global Propranolol Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Propranolol Drug Revenue Market Share by Company (2021-2026) Table 30. Global Propranolol Drug Sales by Company (2021-2026) & (K Units) Table 31. Global Propranolol Drug Sales Share by Company (2021-2026) Table 32. Global Propranolol Drug Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Propranolol Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Propranolol Drug Major Company Production Sites and Headquarters Table 35. Global Propranolol Drug Company, Product Type & Application Table 36. Global Propranolol Drug Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Propranolol Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Propranolol Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Propranolol Drug Sales by Region (2021-2026) & (K Units) Table 41. Global Propranolol Drug Sales Market Share in Volume by Region (2021-2026) Table 42. Global Propranolol Drug Sales by Region (2021-2026) & (US$ Million) Table 43. Global Propranolol Drug Sales Market Share in Value by Region (2021-2026) Table 44. Global Propranolol Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Propranolol Drug Sales by Region (2027-2032) & (K Units) Table 46. Global Propranolol Drug Sales Market Share in Volume by Region (2027-2032) Table 47. Global Propranolol Drug Sales by Region (2027-2032) & (US$ Million) Table 48. Global Propranolol Drug Sales Market Share in Value by Region (2027-2032) Table 49. Global Propranolol Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Propranolol Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Propranolol Drug Sales by Application (2021-2026) & (K Units) Table 52. Global Propranolol Drug Sales Market Share in Volume by Application (2021-2026) Table 53. Global Propranolol Drug Sales by Application (2021-2026) & (US$ Million) Table 54. Global Propranolol Drug Sales Market Share in Value by Application (2021-2026) Table 55. Global Propranolol Drug Price by Application (2021-2026) & (US$/Unit) Table 56. Global Propranolol Drug Sales by Application (2027-2032) & (K Units) Table 57. Global Propranolol Drug Sales Market Share in Volume by Application (2027-2032) Table 58. Global Propranolol Drug Sales by Application (2027-2032) & (US$ Million) Table 59. Global Propranolol Drug Sales Market Share in Value by Application (2027-2032) Table 60. Global Propranolol Drug Price by Application (2027-2032) & (US$/Unit) Table 61. North America Propranolol Drug Sales by Application (2021-2026) & (K Units) Table 62. North America Propranolol Drug Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Propranolol Drug Sales by Application (2021-2026) & (K Units) Table 64. Europe Propranolol Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Propranolol Drug Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Propranolol Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Propranolol Drug Sales by Application (2021-2026) & (K Units) Table 68. Latin America Propranolol Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Propranolol Drug Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Propranolol Drug Sales by Application (2021-2026) & (US$ Million) Table 71. ABZ-Pharma Company Information Table 72. ABZ-Pharma Business Overview Table 73. ABZ-Pharma Propranolol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. ABZ-Pharma Propranolol Drug Product Portfolio Table 75. ABZ-Pharma Recent Development Table 76. Apotex Company Information Table 77. Apotex Business Overview Table 78. Apotex Propranolol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Apotex Propranolol Drug Product Portfolio Table 80. Apotex Recent Development Table 81. Atnahs Pharma Company Information Table 82. Atnahs Pharma Business Overview Table 83. Atnahs Pharma Propranolol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Atnahs Pharma Propranolol Drug Product Portfolio Table 85. Atnahs Pharma Recent Development Table 86. IFET Company Information Table 87. IFET Business Overview Table 88. IFET Propranolol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. IFET Propranolol Drug Product Portfolio Table 90. IFET Recent Development Table 91. Intas Pharma Company Information Table 92. Intas Pharma Business Overview Table 93. Intas Pharma Propranolol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Intas Pharma Propranolol Drug Product Portfolio Table 95. Intas Pharma Recent Development Table 96. Iqfarma Company Information Table 97. Iqfarma Business Overview Table 98. Iqfarma Propranolol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Iqfarma Propranolol Drug Product Portfolio Table 100. Iqfarma Recent Development Table 101. Nichi-Iko Pharmaceutical Company Information Table 102. Nichi-Iko Pharmaceutical Business Overview Table 103. Nichi-Iko Pharmaceutical Propranolol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Nichi-Iko Pharmaceutical Propranolol Drug Product Portfolio Table 105. Nichi-Iko Pharmaceutical Recent Development Table 106. Sawai Seiyaku Company Information Table 107. Sawai Seiyaku Business Overview Table 108. Sawai Seiyaku Propranolol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Sawai Seiyaku Propranolol Drug Product Portfolio Table 110. Sawai Seiyaku Recent Development Table 111. Towa Yakuhin Company Information Table 112. Towa Yakuhin Business Overview Table 113. Towa Yakuhin Propranolol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Towa Yakuhin Propranolol Drug Product Portfolio Table 115. Towa Yakuhin Recent Development Table 116. Viatris Company Information Table 117. Viatris Business Overview Table 118. Viatris Propranolol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Viatris Propranolol Drug Product Portfolio Table 120. Viatris Recent Development Table 121. Yabang Pharma Company Information Table 122. Yabang Pharma Business Overview Table 123. Yabang Pharma Propranolol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Yabang Pharma Propranolol Drug Product Portfolio Table 125. Yabang Pharma Recent Development Table 126. Zentiva Company Information Table 127. Zentiva Business Overview Table 128. Zentiva Propranolol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Zentiva Propranolol Drug Product Portfolio Table 130. Zentiva Recent Development Table 131. Zydus Pharma Company Information Table 132. Zydus Pharma Business Overview Table 133. Zydus Pharma Propranolol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Zydus Pharma Propranolol Drug Product Portfolio Table 135. Zydus Pharma Recent Development Table 136. AstraZeneca Company Information Table 137. AstraZeneca Business Overview Table 138. AstraZeneca Propranolol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. AstraZeneca Propranolol Drug Product Portfolio Table 140. AstraZeneca Recent Development Table 141. Novartis Company Information Table 142. Novartis Business Overview Table 143. Novartis Propranolol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Novartis Propranolol Drug Product Portfolio Table 145. Novartis Recent Development Table 146. Sanofi Company Information Table 147. Sanofi Business Overview Table 148. Sanofi Propranolol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Sanofi Propranolol Drug Product Portfolio Table 150. Sanofi Recent Development Table 151. Teva Company Information Table 152. Teva Business Overview Table 153. Teva Propranolol Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Teva Propranolol Drug Product Portfolio Table 155. Teva Recent Development Table 156. North America Propranolol Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. North America Propranolol Drug Sales by Country (2021-2026) & (K Units) Table 158. North America Propranolol Drug Sales Market Share by Country (2021-2026) Table 159. North America Propranolol Drug Sales Forecast by Country (2027-2032) & (K Units) Table 160. North America Propranolol Drug Sales Market Share Forecast by Country (2027-2032) Table 161. North America Propranolol Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. North America Propranolol Drug Market Size by Country (2021-2026) & (US$ Million) Table 163. North America Propranolol Drug Market Share by Country (2021-2026) Table 164. North America Propranolol Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. North America Propranolol Drug Market Share Forecast by Country (2027-2032) Table 166. Europe Propranolol Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Europe Propranolol Drug Sales by Country (2021-2026) & (K Units) Table 168. Europe Propranolol Drug Sales Market Share by Country (2021-2026) Table 169. Europe Propranolol Drug Sales Forecast by Country (2027-2032) & (K Units) Table 170. Europe Propranolol Drug Sales Market Share Forecast by Country (2027-2032) Table 171. Europe Propranolol Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Europe Propranolol Drug Market Size by Country (2021-2026) & (US$ Million) Table 173. Europe Propranolol Drug Market Share by Country (2021-2026) Table 174. Europe Propranolol Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Europe Propranolol Drug Market Share Forecast by Country (2027-2032) Table 176. Asia-Pacific Propranolol Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. Asia-Pacific Propranolol Drug Sales by Country (2021-2026) & (K Units) Table 178. Asia-Pacific Propranolol Drug Sales Market Share by Country (2021-2026) Table 179. Asia-Pacific Propranolol Drug Sales Forecast by Country (2027-2032) & (K Units) Table 180. Asia-Pacific Propranolol Drug Sales Market Share Forecast by Country (2027-2032) Table 181. Asia-Pacific Propranolol Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Asia-Pacific Propranolol Drug Market Size by Country (2021-2026) & (US$ Million) Table 183. Asia-Pacific Propranolol Drug Market Share by Country (2021-2026) Table 184. Asia-Pacific Propranolol Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Asia-Pacific Propranolol Drug Market Share Forecast by Country (2027-2032) Table 186. Latin America Propranolol Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 187. Latin America Propranolol Drug Sales by Country (2021-2026) & (K Units) Table 188. Latin America Propranolol Drug Sales Market Share by Country (2021-2026) Table 189. Latin America Propranolol Drug Sales Forecast by Country (2027-2032) & (K Units) Table 190. Latin America Propranolol Drug Sales Market Share Forecast by Country (2027-2032) Table 191. Latin America Propranolol Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Latin America Propranolol Drug Market Size by Country (2021-2026) & (US$ Million) Table 193. Latin America Propranolol Drug Market Share by Country (2021-2026) Table 194. Latin America Propranolol Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Latin America Propranolol Drug Market Share Forecast by Country (2027-2032) Table 196. Middle East and Africa Propranolol Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 197. Middle East and Africa Propranolol Drug Sales by Country (2021-2026) & (K Units) Table 198. Middle East and Africa Propranolol Drug Sales Market Share by Country (2021-2026) Table 199. Middle East and Africa Propranolol Drug Sales Forecast by Country (2027-2032) & (K Units) Table 200. Middle East and Africa Propranolol Drug Sales Market Share Forecast by Country (2027-2032) Table 201. Middle East and Africa Propranolol Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. Middle East and Africa Propranolol Drug Market Size by Country (2021-2026) & (US$ Million) Table 203. Middle East and Africa Propranolol Drug Market Share by Country (2021-2026) Table 204. Middle East and Africa Propranolol Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. Middle East and Africa Propranolol Drug Market Share Forecast by Country (2027-2032) Table 206. Key Raw Materials Table 207. Raw Materials Key Suppliers Table 208. Propranolol Drug Distributors List Table 209. Propranolol Drug Customers List Table 210. Research Programs/Design for This Report Table 211. Authors List of This Report Table 212. Secondary Sources Table 213. Primary Sources List of Figures Figure 1. Propranolol Drug Image Figure 2. Global Propranolol Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Propranolol Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Propranolol Drug Sales (2021-2032) & (K Units) Figure 5. Oral Image Figure 6. Global Oral Sales YoY Growth (2021-2032) & (K Units) Figure 7. Injection Image Figure 8. Global Injection Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Propranolol Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Propranolol Drug Market Share by Type 2025 VS 2032 Figure 11. North America Propranolol Drug Sales Market Share in Volume by Type in 2025 Figure 12. North America Propranolol Drug Sales Market Share in Value by Type in 2025 Figure 13. Europe Propranolol Drug Sales Market Share in Volume by Type in 2025 Figure 14. Europe Propranolol Drug Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Propranolol Drug Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Propranolol Drug Sales Market Share in Value by Type in 2025 Figure 17. Latin America Propranolol Drug Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Propranolol Drug Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Propranolol Drug Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Propranolol Drug Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Propranolol Drug Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Arrhythmia Image Figure 24. Global Arrhythmia Sales YoY Growth (2021-2032) & (K Units) Figure 25. Hypertension Image Figure 26. Global Hypertension Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Propranolol Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Propranolol Drug Market Share by Application 2025 VS 2032 Figure 31. North America Propranolol Drug Sales Market Share in Volume by Application in 2025 Figure 32. North America Propranolol Drug Sales Market Share in Value by Application in 2025 Figure 33. Europe Propranolol Drug Sales Market Share in Volume by Application in 2025 Figure 34. Europe Propranolol Drug Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Propranolol Drug Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Propranolol Drug Sales Market Share in Value by Application in 2025 Figure 37. Latin America Propranolol Drug Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Propranolol Drug Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Propranolol Drug Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Propranolol Drug Sales Market Share in Value by Application in 2025 Figure 41. North America Propranolol Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Propranolol Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Propranolol Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Propranolol Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Propranolol Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Propranolol Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Propranolol Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Propranolol Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Propranolol Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Propranolol Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Propranolol Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Propranolol Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Propranolol Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Propranolol Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Propranolol Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Propranolol Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Propranolol Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Propranolol Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Propranolol Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Propranolol Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Propranolol Drug Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Propranolol Drug Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injection
Applications
  • Arrhythmia
  • Hypertension
  • Other
Companies covered
  • ABZ-Pharma
  • Apotex
  • Atnahs Pharma
  • IFET
  • Intas Pharma
  • Iqfarma
  • Nichi-Iko Pharmaceutical
  • Sawai Seiyaku
  • Towa Yakuhin
  • Viatris
  • Yabang Pharma
  • Zentiva
  • Zydus Pharma
  • AstraZeneca
  • Novartis
  • Sanofi
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Propranolol Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Propranolol Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Propranolol Drug Market by Type
  6. 1.3.1 Oral
  7. 1.3.2 Injection
  8. 1.4 Global Propranolol Drug Market Size by Type
  9. 1.4.1 Global Propranolol Drug Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Propranolol Drug Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Propranolol Drug Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Propranolol Drug Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Propranolol Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Propranolol Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Propranolol Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Propranolol Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Propranolol Drug Industry Trends
  2. 2.2 Propranolol Drug Industry Drivers
  3. 2.3 Propranolol Drug Industry Opportunities and Challenges
  4. 2.4 Propranolol Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Propranolol Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Propranolol Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Propranolol Drug Price (2021-2026)
  4. 3.4 Global Propranolol Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Propranolol Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Propranolol Drug Company, Product Type & Application
  7. 3.7 Global Propranolol Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Propranolol Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Propranolol Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Propranolol Drug Tier 1, Tier 2, and Tier 3
4 Propranolol Drug Regional Status and Outlook
  1. 4.1 Global Propranolol Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Propranolol Drug Historic Market Size by Region
  3. 4.2.1 Global Propranolol Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Propranolol Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Propranolol Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Propranolol Drug Forecasted Market Size by Region
  7. 4.3.1 Global Propranolol Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Propranolol Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Propranolol Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Propranolol Drug by Application
  1. 5.1 Propranolol Drug Market by Application
  2. 5.1.1 Arrhythmia
  3. 5.1.2 Hypertension
  4. 5.1.3 Other
  5. 5.2 Global Propranolol Drug Market Size by Application
  6. 5.2.1 Global Propranolol Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Propranolol Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Propranolol Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Propranolol Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Propranolol Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Propranolol Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Propranolol Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Propranolol Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 ABZ-Pharma
  2. 6.1.1 ABZ-Pharma Company Information
  3. 6.1.2 ABZ-Pharma Business Overview
  4. 6.1.3 ABZ-Pharma Propranolol Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 ABZ-Pharma Propranolol Drug Product Portfolio
  6. 6.1.5 ABZ-Pharma Recent Developments
  7. 6.2 Apotex
  8. 6.2.1 Apotex Company Information
  9. 6.2.2 Apotex Business Overview
  10. 6.2.3 Apotex Propranolol Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Apotex Propranolol Drug Product Portfolio
  12. 6.2.5 Apotex Recent Developments
  13. 6.3 Atnahs Pharma
  14. 6.3.1 Atnahs Pharma Company Information
  15. 6.3.2 Atnahs Pharma Business Overview
  16. 6.3.3 Atnahs Pharma Propranolol Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Atnahs Pharma Propranolol Drug Product Portfolio
  18. 6.3.5 Atnahs Pharma Recent Developments
  19. 6.4 IFET
  20. 6.4.1 IFET Company Information
  21. 6.4.2 IFET Business Overview
  22. 6.4.3 IFET Propranolol Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 IFET Propranolol Drug Product Portfolio
  24. 6.4.5 IFET Recent Developments
  25. 6.5 Intas Pharma
  26. 6.5.1 Intas Pharma Company Information
  27. 6.5.2 Intas Pharma Business Overview
  28. 6.5.3 Intas Pharma Propranolol Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Intas Pharma Propranolol Drug Product Portfolio
  30. 6.5.5 Intas Pharma Recent Developments
  31. 6.6 Iqfarma
  32. 6.6.1 Iqfarma Company Information
  33. 6.6.2 Iqfarma Business Overview
  34. 6.6.3 Iqfarma Propranolol Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Iqfarma Propranolol Drug Product Portfolio
  36. 6.6.5 Iqfarma Recent Developments
  37. 6.7 Nichi-Iko Pharmaceutical
  38. 6.7.1 Nichi-Iko Pharmaceutical Company Information
  39. 6.7.2 Nichi-Iko Pharmaceutical Business Overview
  40. 6.7.3 Nichi-Iko Pharmaceutical Propranolol Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Nichi-Iko Pharmaceutical Propranolol Drug Product Portfolio
  42. 6.7.5 Nichi-Iko Pharmaceutical Recent Developments
  43. 6.8 Sawai Seiyaku
  44. 6.8.1 Sawai Seiyaku Company Information
  45. 6.8.2 Sawai Seiyaku Business Overview
  46. 6.8.3 Sawai Seiyaku Propranolol Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sawai Seiyaku Propranolol Drug Product Portfolio
  48. 6.8.5 Sawai Seiyaku Recent Developments
  49. 6.9 Towa Yakuhin
  50. 6.9.1 Towa Yakuhin Company Information
  51. 6.9.2 Towa Yakuhin Business Overview
  52. 6.9.3 Towa Yakuhin Propranolol Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Towa Yakuhin Propranolol Drug Product Portfolio
  54. 6.9.5 Towa Yakuhin Recent Developments
  55. 6.10 Viatris
  56. 6.10.1 Viatris Company Information
  57. 6.10.2 Viatris Business Overview
  58. 6.10.3 Viatris Propranolol Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Viatris Propranolol Drug Product Portfolio
  60. 6.10.5 Viatris Recent Developments
  61. 6.11 Yabang Pharma
  62. 6.11.1 Yabang Pharma Company Information
  63. 6.11.2 Yabang Pharma Business Overview
  64. 6.11.3 Yabang Pharma Propranolol Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Yabang Pharma Propranolol Drug Product Portfolio
  66. 6.11.5 Yabang Pharma Recent Developments
  67. 6.12 Zentiva
  68. 6.12.1 Zentiva Company Information
  69. 6.12.2 Zentiva Business Overview
  70. 6.12.3 Zentiva Propranolol Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Zentiva Propranolol Drug Product Portfolio
  72. 6.12.5 Zentiva Recent Developments
  73. 6.13 Zydus Pharma
  74. 6.13.1 Zydus Pharma Company Information
  75. 6.13.2 Zydus Pharma Business Overview
  76. 6.13.3 Zydus Pharma Propranolol Drug Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Zydus Pharma Propranolol Drug Product Portfolio
  78. 6.13.5 Zydus Pharma Recent Developments
  79. 6.14 AstraZeneca
  80. 6.14.1 AstraZeneca Company Information
  81. 6.14.2 AstraZeneca Business Overview
  82. 6.14.3 AstraZeneca Propranolol Drug Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 AstraZeneca Propranolol Drug Product Portfolio
  84. 6.14.5 AstraZeneca Recent Developments
  85. 6.15 Novartis
  86. 6.15.1 Novartis Company Information
  87. 6.15.2 Novartis Business Overview
  88. 6.15.3 Novartis Propranolol Drug Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Novartis Propranolol Drug Product Portfolio
  90. 6.15.5 Novartis Recent Developments
  91. 6.16 Sanofi
  92. 6.16.1 Sanofi Company Information
  93. 6.16.2 Sanofi Business Overview
  94. 6.16.3 Sanofi Propranolol Drug Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Sanofi Propranolol Drug Product Portfolio
  96. 6.16.5 Sanofi Recent Developments
  97. 6.17 Teva
  98. 6.17.1 Teva Company Information
  99. 6.17.2 Teva Business Overview
  100. 6.17.3 Teva Propranolol Drug Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Teva Propranolol Drug Product Portfolio
  102. 6.17.5 Teva Recent Developments
7 North America by Country
  1. 7.1 North America Propranolol Drug Sales by Country
  2. 7.1.1 North America Propranolol Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Propranolol Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Propranolol Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Propranolol Drug Market Size by Country
  6. 7.2.1 North America Propranolol Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Propranolol Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Propranolol Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Propranolol Drug Sales by Country
  2. 8.1.1 Europe Propranolol Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Propranolol Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Propranolol Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Propranolol Drug Market Size by Country
  6. 8.2.1 Europe Propranolol Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Propranolol Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Propranolol Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Propranolol Drug Sales by Country
  2. 9.1.1 Asia-Pacific Propranolol Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Propranolol Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Propranolol Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Propranolol Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Propranolol Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Propranolol Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Propranolol Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Propranolol Drug Sales by Country
  2. 10.1.1 South America Propranolol Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Propranolol Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Propranolol Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Propranolol Drug Market Size by Country
  6. 10.2.1 South America Propranolol Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Propranolol Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Propranolol Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Propranolol Drug Sales by Country
  2. 11.1.1 Middle East and Africa Propranolol Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Propranolol Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Propranolol Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Propranolol Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Propranolol Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Propranolol Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Propranolol Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Propranolol Drug Value Chain Analysis
  2. 12.1.1 Propranolol Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Propranolol Drug Production Mode & Process
  7. 12.2 Propranolol Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Propranolol Drug Distributors
  10. 12.2.3 Propranolol Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst